Low testosterone (hypogonadism) can drain energy, motivation, muscle, libido, and confidence. It is a medical condition and the right approach starts with correct testing, then addresses root causes like sleep apnea, weight, and diabetes, and finally uses treatment when criteria are met. Modern guidelines, cardiovascular safety data, and updated drug labels give men and clinicians a clear and safe path forward.
What low testosterone is
Clinically, low testosterone means symptoms consistent with androgen deficiency plus consistently low morning total testosterone on two separate days, with free testosterone or SHBG considered when results are borderline. Diagnosis is never lab numbers alone. [1][2]
Common symptoms: low morning energy, low libido, fewer morning erections, depressed mood or irritability, loss of muscle with central fat gain, reduced exercise tolerance, infertility concerns. [1]
How to test correctly (and avoid false alarms)
- Timing: draw morning samples, ideally fasting. Repeat on a different day before making decisions. [1]
- Confirm and investigate: if total testosterone is borderline, consider free testosterone or SHBG based on clinician judgement. Check contributors like obesity, diabetes, thyroid disease, hyperprolactinemia, medications, and obstructive sleep apnea. Recent urology guidance flags OSA screening before starting therapy. [1][2]
- When not to test: routine screening in men without symptoms is not recommended. Testing should follow symptoms and clinical suspicion. [1]
Why testosterone can be low
- Excess weight and insulin resistance: central fat increases aromatase activity and suppresses the HPG axis.
- Chronic illness: diabetes, metabolic liver disease, kidney disease, and inflammatory conditions.
- Sleep apnea: associated with lower testosterone and sexual symptoms; treat OSA to improve outcomes. [2]
- Medications and substances: chronic opioids, some steroids, androgens used for bodybuilding, and certain endocrine-active drugs.
- Primary testicular failure or secondary pituitary-hypothalamic causes: require targeted work-up. [1]
Start with foundations that raise testosterone naturally
- Reduce central fat: protein-forward meals, fewer refined carbs, consistent caloric control.
- Train smart: 2 strength sessions weekly, plus brisk walking most days.
- Sleep: 7 to 9 hours, treat suspected OSA, keep a fixed sleep window.
- Quit smoking: improves blood flow and testicular health, which can help testosterone levels recover over time.
These steps often improve symptoms and testosterone, and they also boost the response and safety profile if therapy is needed later. [1][2]
When treatment is considered
Therapy is appropriate only when symptoms align and repeated morning tests are low after addressing reversible factors. Choice of formulation depends on preference, comorbidities, fertility goals, and monitoring needs. [1]
Formulations used in practice: injections, transdermal gels or patches, and other approved routes. The AUA 2024 update highlights practical pre-treatment checks, including OSA and cardiometabolic risk, then a shared monitoring plan. [2]
Cardiovascular safety, the 2024–2025 picture
There has been long-standing debate about TRT and the heart. The most recent evidence is reassuring when treatment is prescribed for true hypogonadism and monitored correctly: multiple 2024 meta-analyses and position papers show no excess major adverse cardiovascular events compared with placebo or usual care. [3][4][9]
In February 2025, the FDA updated class-wide labels to reflect trial data that did not show increased MACE risk, while adding a clear blood pressure warning and advising label harmonization across products. Individual labels were updated in 2025 to include hypertension language. [5][6]
What this means for patients:
- Optimize blood pressure, lipids, weight, and sleep before or alongside therapy.
- Review cardiac history and medications, then monitor per plan. Done properly, contemporary data support cardiovascular safety. [3][4][5][6][9]
Fertility first, always
Exogenous testosterone suppresses pituitary signals and can decrease or stop sperm production. If you hope to conceive in the near term, speak up before starting therapy. AUA/ASRM 2024 recommends fertility-preserving strategies when needed, like hCG followed by FSH to stimulate endogenous testosterone in the testes and support sperm production. Recent 2025 clinical data show encouraging recovery of spermatogenesis on hCG/FSH protocols in men with prior testosterone exposure. [7][8][2]
Practical options before TRT if family building is a goal: weight loss, sleep apnea treatment, and endocrine-directed regimens (hCG ± FSH) under specialist care. Bank sperm when appropriate. [7][8]
Safety and monitoring checklist
- Before starting: confirm diagnosis, evaluate OSA, check hematocrit, PSA as appropriate, blood pressure, lipids, and glucose. [1][2][5]
- After starting: periodic symptom review, testosterone levels to maintain therapeutic range, hematocrit to avoid erythrocytosis, blood pressure checks, and prostate monitoring as indicated. [1][2][5][6]
- When to pause or reassess: rising hematocrit, uncontrolled hypertension, new cardiac symptoms, or if fertility goals change.
Frequently asked questions
1) Will testosterone therapy fix erections on its own?
Not if low T is not the main driver. In men with confirmed deficiency it can improve desire and energy, and can enhance ED treatment response. Vascular and metabolic risks still need attention. [1]
2) Is therapy lifelong?
Not necessarily. Duration depends on symptoms, labs, and life plans. As weight, sleep, and comorbidities improve, some men can taper after a supervised trial off therapy. [1][2]
3) I have heart risk. Is TRT safe for me?
Discuss personal risk with your clinician. Recent meta-analyses and position statements did not show increased MACE with guideline-driven TRT, and the FDA label now reflects updated cardiovascular data, with a new emphasis on blood pressure monitoring. [3][4][5][6][9]
4) Can I preserve fertility while improving testosterone-related symptoms?
Yes. In some men, specialist protocols using hCG ± FSH can restore or support spermatogenesis, with promising 2025 results. Avoid starting exogenous testosterone until you discuss a fertility plan. [7][8]
5) What if my morning testosterone is “borderline”?
Repeat it, consider free testosterone or SHBG, and address sleep, weight, and medications. Treatment decisions combine symptoms, repeated labs, and clinical judgement. [1][2]
—
References
[1] European Association of Urology. Guidelines on Sexual and Reproductive Health — Male Hypogonadism (2024).
https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/male-hypogonadism
[2] American Urological Association. Update to the Testosterone Deficiency Guideline (April 2024).
https://www.auajournals.org/doi/10.1097/JU.0000000000003855
[3] Androgen Society. Position paper on cardiovascular risk with testosterone therapy (2024).
https://www.mayoclinicproceedings.org/article/S0025-6196%2824%2900408-7/fulltext
[4] Journal of the American College of Cardiology. Updated meta-analysis on cardiovascular outcomes with testosterone therapy (2024).
https://www.jacc.org/doi/10.1016/S0735-1097%2824%2903712-4
[5] U.S. Food and Drug Administration. Class-wide labeling changes for testosterone products (Feb 28, 2025).
https://www.fda.gov/drugs/drug-safety-and-availability/fda-issues-class-wide-labeling-changes-testosterone-products
[6] U.S. FDA label example with blood-pressure warning (revised July 2025). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209863s020lbl.pdf
[7] American Urological Association and American Society for Reproductive Medicine. Male Infertility Guideline, amended 2024 (full PDF). https://www.auanet.org/documents/Guidelines/PDF/2024%20Guidelines/Male%20Infertility%20Unabridged%20Final.pdf
[8] Stocks BT, et al. Optimal restoration of spermatogenesis after testosterone use with hCG and FSH (2025).
https://pubmed.ncbi.nlm.nih.gov/39442683/
[9] Andrology. Expert panel review on cardiovascular safety of testosterone therapy (May 2025).
https://onlinelibrary.wiley.com/doi/10.1111/andr.70062
[10] International Consultation for Sexual Medicine. Male hypogonadism recommendations (Sexual Medicine Reviews, 2025).
https://academic.oup.com/smr/article/13/4/548/8242145